Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized Phase II, Open-Label Study of the Efficacy and Safety of Orally Administered SAR302503 in Patients With Polycythemia Vera (PV) or Essential Thrombocythemia (ET) Who are Resistant or Intolerant to Hydroxyurea.
Closed to Accrual with Ongoing Follow-up
Defintions of terms and FAQ about clinical trials.
Casey O Connell, M.D.
Other Trial Staff:
Melissa Peralta, D.M., TehChun Wang, R.N., Teresa Olea, R.N.
to see study documents.
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.